Biome Analytics Introduces AI-Powered Documentation Audit Product to Enhance Cardiovascular Data Accuracy and Revenue Optimization

SAN FRANCISCO--(BUSINESS WIRE)--Biome Analytics, the leader in cardiovascular performance improvement solutions, is pleased to announce the launch of its latest innovation, the Biome Risk Audit. Developed to address challenges in risk reporting and documentation accuracy in cardiovascular care, this artificial intelligence (AI) enabled tool integrates traditionally siloed quality data and billing information to improve publicly reported outcomes and maximize revenue opportunities.

The Biome Risk Audit solves longstanding challenges with risk reporting and documentation accuracy. By comparing manually abstracted quality data with billing/coding data, this solution enables healthcare organizations to capture patient risk more accurately, improve quality rankings, and maximize reimbursement.

"At Biome, we understand the critical importance of accurate risk reporting and documentation in cardiovascular care," says Matthew Esham, Biome's Vice President of Analytics. "Our Bi-Directional Risk Audit Engine provides cardiovascular teams with practical tools to enhance documentation accuracy and revenue, saving healthcare teams hundreds of hours."

One early-release client identified a 37% under-documentation of comorbidities like diabetes. Another client improved their observed-to-expected ratio by 30%. Both organizations realized revenue and margin improvements in just one-quarter of usage.

About Biome

Biome is a leading provider of innovative healthcare technology solutions. With a focus on transforming patient care and optimizing operational efficiency, Biome develops cutting-edge software and tools that empower healthcare providers to deliver exceptional outcomes. By leveraging advanced technologies, such as machine learning and artificial intelligence, Biome is revolutionizing the healthcare industry one solution at a time.